---
title: "CRNX.US (CRNX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/CRNX.US/news.md"
symbol: "CRNX.US"
name: "CRNX.US"
parent: "https://longbridge.com/en/quote/CRNX.US.md"
datetime: "2026-05-21T08:08:03.856Z"
locales:
  - [en](https://longbridge.com/en/quote/CRNX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/CRNX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/CRNX.US/news.md)
---

# CRNX.US (CRNX.US) — Related News

### [3 Best Healthcare Stocks to Buy in May 2026, According to Analysts](https://longbridge.com/en/news/286619134.md)
*2026-05-15T21:28:05.000Z*
> Healthcare stocks are back in focus this month as investors look for strong pipelines and steady growth in a market stil

### [HC Wainwright Has Negative Estimate for CRNX FY2030 Earnings](https://longbridge.com/en/news/285887821.md)
*2026-05-11T05:55:38.000Z*
> HC Wainwright has revised its FY2030 earnings estimate for Crinetics Pharmaceuticals (NASDAQ:CRNX), lowering it from $2.

### [](https://longbridge.com/en/news/285759921.md)
*2026-05-08T17:36:45.000Z*
> Crinetics Pharmaceuticals shares are trading lower after Citizens lowered its price target on the stock from $97 to $95.

### [Crinetics (CRNX) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/285744298.md)
*2026-05-08T14:45:16.000Z*
> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of

### [Piper Sandler Remains a Buy on Crinetics Pharmaceuticals (CRNX)](https://longbridge.com/en/news/285730549.md)
*2026-05-08T13:04:57.000Z*
> Piper Sandler analyst Yasmeen Rahimi has maintained a Buy rating on Crinetics Pharmaceuticals (CRNX) with a price target

### [Crinetics Pharmaceuticals | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 10.73 M](https://longbridge.com/en/news/285613825.md)
*2026-05-07T20:34:32.000Z*
### [Jennison Associates LLC Sells 763,133 Shares of Crinetics Pharmaceuticals, Inc. $CRNX](https://longbridge.com/en/news/284886894.md)
*2026-05-01T10:49:26.000Z*
> Jennison Associates LLC has reduced its stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) by 37.3%, selling 763,133

### [Weekly Buzz: FDA Okays Saphnelo Pen, EC Clears Acromegaly Drug, SNGX Slumps, LGND Snaps Up XOMA](https://longbridge.com/en/news/284786732.md)
*2026-04-30T13:54:03.000Z*
> This week's biotech news highlights significant regulatory approvals and acquisitions. Crinetics received EU approval fo